{"id":747202,"date":"2023-04-12T16:43:09","date_gmt":"2023-04-12T20:43:09","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-present-at-upcoming-investor-conferences-in-april\/"},"modified":"2023-04-12T16:43:09","modified_gmt":"2023-04-12T20:43:09","slug":"geron-to-present-at-upcoming-investor-conferences-in-april","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-present-at-upcoming-investor-conferences-in-april\/","title":{"rendered":"Geron to Present at Upcoming Investor Conferences in April"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Geron to Present at Upcoming Investor Conferences in April<\/b><\/p>\n<p>FOSTER CITY, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nGeron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron\u2019s Chairman and Chief Executive Officer, is scheduled to participate in fireside chats at following investor conferences:<\/p>\n<ul class=\"bwlistdisc\">\n<li><b>22<sup>nd<\/sup> Annual Needham Virtual Healthcare Conference<br \/>\n<br \/><\/b>Thursday, April 20 at 10:15 a.m. ET<\/p>\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><b>Stifel 2023 Virtual Targeted Oncology Days<br \/>\n<br \/><\/b>Tuesday, April 25 at 2:00 p.m. ET<\/p>\n<\/li>\n<\/ul>\n<p>\nA webcast of each fireside chat and corporate presentation will be available through the Investor Relations section of Geron\u2019s website under <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.geron.com%2Finvestors%2Fevents%2Fdefault.aspx&amp;esheet=53380216&amp;newsitemid=20230412005663&amp;lan=en-US&amp;anchor=Events&amp;index=1&amp;md5=d5b5876ab0c6869334ed790ad84d8f8b\">Events<\/a>. Following each scheduled conference event, the related webcast will be archived and available for replay for a period of 30 days.<\/p>\n<p><b>About Geron<\/b><\/p>\n<p>\nGeron is a late-stage biopharmaceutical company pursuing therapies with the potential to extend and enrich the lives of patients living with hematologic malignancies. Its investigational first-in-class telomerase inhibitor, imetelstat, harnesses Nobel Prize winning science in a treatment that may alter the underlying course of these diseases. To learn more, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.geron.com%2F&amp;esheet=53380216&amp;newsitemid=20230412005663&amp;lan=en-US&amp;anchor=http%3A%2F%2Fwww.geron.com%2F&amp;index=2&amp;md5=f6e5b7420ecb19bb39cbc8446f56505d\">http:\/\/www.geron.com\/<\/a>or follow us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2F163982%2Fadmin%2F&amp;esheet=53380216&amp;newsitemid=20230412005663&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=3&amp;md5=bbc4f1770fea44ee515363a5d7359f0d\">LinkedIn<\/a>.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230412005663r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20230412005663\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20230412005663\/en\/<\/a><\/span><\/p>\n<p>\nAron Feingold<br \/>\n<br \/>Investor and Media Relations<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:investor@geron.com\">investor@geron.com<br \/>\n<\/a><br \/><a rel=\"nofollow\" href=\"mailto:media@geron.com\">media@geron.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> California United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Research Hospitals FDA Clinical Trials Other Health Biotechnology Pharmaceutical Health Science Oncology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230412005663\/en\/1626764\/3\/Geron_Full_Logo_RGB-01.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Geron to Present at Upcoming Investor Conferences in April FOSTER CITY, Calif.&#8211;(BUSINESS WIRE)&#8211; Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron\u2019s Chairman and Chief Executive Officer, is scheduled to participate in fireside chats at following investor conferences: 22nd Annual Needham Virtual Healthcare Conference Thursday, April 20 at 10:15 a.m. ET Stifel 2023 Virtual Targeted Oncology Days Tuesday, April 25 at 2:00 p.m. ET A webcast of each fireside chat and corporate presentation will be available through the Investor Relations section of Geron\u2019s website under Events. Following each scheduled conference event, the related webcast will be archived and available for replay for a period of 30 days. About Geron Geron is a &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-present-at-upcoming-investor-conferences-in-april\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Geron to Present at Upcoming Investor Conferences in April&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-747202","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Geron to Present at Upcoming Investor Conferences in April - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-present-at-upcoming-investor-conferences-in-april\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Geron to Present at Upcoming Investor Conferences in April - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Geron to Present at Upcoming Investor Conferences in April FOSTER CITY, Calif.&#8211;(BUSINESS WIRE)&#8211; Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron\u2019s Chairman and Chief Executive Officer, is scheduled to participate in fireside chats at following investor conferences: 22nd Annual Needham Virtual Healthcare Conference Thursday, April 20 at 10:15 a.m. ET Stifel 2023 Virtual Targeted Oncology Days Tuesday, April 25 at 2:00 p.m. ET A webcast of each fireside chat and corporate presentation will be available through the Investor Relations section of Geron\u2019s website under Events. Following each scheduled conference event, the related webcast will be archived and available for replay for a period of 30 days. About Geron Geron is a &hellip; Continue reading &quot;Geron to Present at Upcoming Investor Conferences in April&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-present-at-upcoming-investor-conferences-in-april\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-12T20:43:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230412005663r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Geron to Present at Upcoming Investor Conferences in April\",\"datePublished\":\"2023-04-12T20:43:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/\"},\"wordCount\":234,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230412005663r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/\",\"name\":\"Geron to Present at Upcoming Investor Conferences in April - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230412005663r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2023-04-12T20:43:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230412005663r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230412005663r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Geron to Present at Upcoming Investor Conferences in April\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Geron to Present at Upcoming Investor Conferences in April - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-present-at-upcoming-investor-conferences-in-april\/","og_locale":"en_US","og_type":"article","og_title":"Geron to Present at Upcoming Investor Conferences in April - Market Newsdesk","og_description":"Geron to Present at Upcoming Investor Conferences in April FOSTER CITY, Calif.&#8211;(BUSINESS WIRE)&#8211; Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron\u2019s Chairman and Chief Executive Officer, is scheduled to participate in fireside chats at following investor conferences: 22nd Annual Needham Virtual Healthcare Conference Thursday, April 20 at 10:15 a.m. ET Stifel 2023 Virtual Targeted Oncology Days Tuesday, April 25 at 2:00 p.m. ET A webcast of each fireside chat and corporate presentation will be available through the Investor Relations section of Geron\u2019s website under Events. Following each scheduled conference event, the related webcast will be archived and available for replay for a period of 30 days. About Geron Geron is a &hellip; Continue reading \"Geron to Present at Upcoming Investor Conferences in April\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-present-at-upcoming-investor-conferences-in-april\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-12T20:43:09+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230412005663r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-present-at-upcoming-investor-conferences-in-april\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-present-at-upcoming-investor-conferences-in-april\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Geron to Present at Upcoming Investor Conferences in April","datePublished":"2023-04-12T20:43:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-present-at-upcoming-investor-conferences-in-april\/"},"wordCount":234,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-present-at-upcoming-investor-conferences-in-april\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230412005663r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-present-at-upcoming-investor-conferences-in-april\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-present-at-upcoming-investor-conferences-in-april\/","name":"Geron to Present at Upcoming Investor Conferences in April - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-present-at-upcoming-investor-conferences-in-april\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-present-at-upcoming-investor-conferences-in-april\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230412005663r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2023-04-12T20:43:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-present-at-upcoming-investor-conferences-in-april\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-present-at-upcoming-investor-conferences-in-april\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-present-at-upcoming-investor-conferences-in-april\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230412005663r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230412005663r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-present-at-upcoming-investor-conferences-in-april\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Geron to Present at Upcoming Investor Conferences in April"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/747202","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=747202"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/747202\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=747202"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=747202"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=747202"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}